MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: CA050947
National Cancer Institute
Grant: CA196664
National Cancer Institute
Grant: CA225730
National Cancer Institute
Grant: CA233084
National Cancer Institute
Grant: CA97098
NCI NIH HHS
Grant: U01 CA233084
NCI NIH HHS
Grant: R01 CA097098
NCI NIH HHS
Grant: U01 CA225730
NCI NIH HHS
Grant: R01 CA196664
NCI NIH HHS
Grant: R01 CA050947
National Institutes of Health
Grant: 5U01CA225730-04
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
National Institutes of Health
Grant: 5R01CA196664-03
Humanized bone marrow-like model to study patient-derived myeloma xenografts
National Institutes of Health
Grant: 1R01CA050947-01A1
CHARACTERIZATION OF GROWTH FACTOR RESPONSIVE B CELLS
National Institutes of Health
Grant: 5R01CA097098-13
Oncogenic Signaling by DF3/MUC1 in Human Breast Cancer
National Institutes of Health
Grant: 1U01CA233084-01
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
FWCI
2.33
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals